Skip to contentM
Microbot Medical Inc.
M
MBOTMicrobot Medical Inc. Q1 2014 · 10-Q
Revenue—
Net Income-$7.62M-$7.62MN/M vs Q1 2013 EPS Diluted-$0.14-$0.14N/M vs Q1 2013 Operating Cash Flow-$6,507,546N/M Free Cash Flowderived-$6,738,235N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Microbot Medical Inc. · CIK 883975 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 14, 2014 · 44 d after period end